Brainsway ROA 2018-2025 | BWAY
Current and historical return on assets (ROA) values for Brainsway (BWAY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Brainsway ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.01B | $0.10B | 6.02% |
| 2024-12-31 | $0.00B | $0.09B | 5.39% |
| 2024-09-30 | $0.00B | $0.07B | 3.01% |
| 2024-06-30 | $0.00B | $0.07B | 1.57% |
| 2024-03-31 | $0.00B | $0.07B | -3.24% |
| 2023-12-31 | $0.00B | $0.06B | -6.56% |
| 2023-09-30 | $-0.01B | $0.06B | -13.06% |
| 2023-06-30 | $-0.01B | $0.06B | -20.55% |
| 2023-03-31 | $-0.01B | $0.06B | -19.55% |
| 2022-12-31 | $-0.01B | $0.06B | -18.77% |
| 2022-09-30 | $-0.01B | $0.07B | -13.84% |
| 2022-06-30 | $-0.01B | $0.07B | -9.49% |
| 2022-03-31 | $-0.01B | $0.07B | -9.43% |
| 2021-12-31 | $-0.01B | $0.08B | -8.00% |
| 2021-09-30 | $-0.01B | $0.07B | -7.75% |
| 2021-06-30 | $0.00B | $0.07B | -7.34% |
| 2021-03-31 | $0.00B | $0.08B | -6.70% |
| 2020-12-31 | $-0.01B | $0.03B | -14.49% |
| 2020-09-30 | $-0.01B | $0.03B | -19.58% |
| 2020-06-30 | $-0.01B | $0.04B | -24.00% |
| 2020-03-31 | $-0.01B | $0.04B | -27.85% |
| 2019-12-31 | $-0.01B | $0.04B | -27.21% |
| 2019-09-30 | $-0.01B | $0.04B | -30.30% |
| 2019-06-30 | $-0.01B | $0.04B | -28.07% |
| 2019-03-31 | $-0.01B | $0.02B | -39.44% |
| 2018-12-31 | $-0.01B | $0.02B | -51.06% |
| 2018-06-30 | $-0.01B | $0.00B | -74.07% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.222B | $0.041B |
| BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.709B | 27.40 |
| Boston Scientific (BSX) | United States | $152.828B | 36.45 |
| Stryker (SYK) | United States | $144.351B | 29.38 |
| EssilorLuxottica (ESLOY) | France | $136.813B | 0.00 |
| Medtronic (MDT) | Ireland | $119.054B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.435B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.857B | 24.46 |
| ResMed (RMD) | United States | $41.627B | 29.73 |
| GE HealthCare Technologies (GEHC) | United States | $32.872B | 15.45 |
| Agilent Technologies (A) | United States | $32.560B | 21.23 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $25.845B | 17.10 |
| Insulet (PODD) | United States | $21.612B | 72.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.638B | 12.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.829B | 0.00 |
| Baxter (BAX) | United States | $12.168B | 9.40 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.599B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.150B | 26.26 |
| Lantheus Holdings (LNTH) | United States | $3.889B | 10.51 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.364B | 23.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.241B | 14.32 |
| Perrigo (PRGO) | Ireland | $3.103B | 7.75 |
| ICU Medical (ICUI) | United States | $2.777B | 18.97 |
| Haemonetics (HAE) | United States | $2.594B | 11.61 |
| LeMaitre Vascular (LMAT) | United States | $2.089B | 44.80 |
| AtriCure (ATRC) | United States | $1.755B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.623B | 10.22 |
| Green Thumb Industries (GTBIF) | United States | $1.509B | 64.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.368B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.240B | 17.67 |
| Phibro Animal Health (PAHC) | United States | $1.139B | 14.56 |
| Acuren (TIC) | United States | $1.138B | 0.00 |
| Neogen (NEOG) | United States | $1.103B | 17.52 |
| BioLife Solutions (BLFS) | United States | $1.085B | 2268.00 |
| InMode (INMD) | Israel | $0.892B | 8.25 |
| Valneva SE (VALN) | France | $0.775B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.746B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.653B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.560B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| ZimVie (ZIMV) | United States | $0.530B | 20.45 |
| Surmodics (SRDX) | United States | $0.506B | 0.00 |
| CeriBell (CBLL) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.414B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.391B | 13.54 |
| Evolus (EOLS) | United States | $0.382B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.347B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.341B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.88 |
| Canopy Growth (CGC) | Canada | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 0.00 |
| Omeros (OMER) | United States | $0.251B | 0.00 |
| Quanterix (QTRX) | United States | $0.237B | 0.00 |
| Cerus (CERS) | United States | $0.232B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.220B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.214B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.203B | 0.00 |
| Exagen (XGN) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.06 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.170B | 0.00 |
| Biote (BTMD) | United States | $0.158B | 4.72 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.79 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.055B | 0.00 |
| Zynex (ZYXI) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 32.50 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.11 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.017B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |